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Robert M. K. W. Lee, PhDa
Objective: We sought to determine the effects of papaverine on human and canine
internal thoracic artery function and structure.
Methods: Vascular function was assessed with wire myography, and apoptosis was
examined with confocal microscopy in arteries stained with ApopTag.
Results: Acetylcholine-induced endothelium-dependent relaxation in phenyleph-
rine-precontracted arteries was significantly impaired by papaverine treatment in
both human and canine internal thoracic arteries (maximal relaxation: 68.35% 
7.13% vs 47.5%  9.32% in human arteries and 74.8%  5.5% vs 34.3%  8.5%
in canine arteries) but not by incubation with acidified saline solution (pH 3.9, which
is equivalent to the pH of 102 mol/L papaverine solution) in canine internal
thoracic arteries. Contraction of human internal thoracic arteries to phenylephrine or
to U46619 was not significantly affected by papaverine treatment and neither was
the contraction of canine internal thoracic arteries to phenylephrine. Total apoptotic
endothelial and smooth muscle cells were significantly greater in papaverine-treated
human and canine internal thoracic arteries.
Conclusions: Papaverine impairs endothelial function and triggers apoptosis of
endothelial and smooth muscle cells of human and canine internal thoracic arteries.
The long-term consequence of this impairment on vascular function is not known.
Until this question is answered, it will be prudent to use other vasodilators that are
less damaging to the internal thoracic artery for cardiac surgery.
Coronary artery bypass grafting (CABG) is widely accepted formyocardial revascularization of patients with extensive coronaryheart disease.1 The internal thoracic artery (ITA) is a better graftconduit than veins because of its long-term survival and rareatherosclerosis.2,3 An analysis of hospital discharge data acrossCanada between 1992 and 19954 and in Ontario from 1981 to
19955 consistently found a decrease in mortality after CABG. This is despite the fact
that there was a steady increase in the mean age of patients undergoing the
procedure, with more of these patients having other coexisting conditions, such as
acute myocardial infarction, pulmonary disease, and diabetes.5
One problem associated with the use of ITAs in CABG is the occurrence of
perioperative vasospasm, which might result in myocardial infarction and postop-
erative morbidity.6 Intraoperatively, it is noted that the ITA might be in spasm
during or after dissection. The release of various vasoconstricting substances during
CABG, which might include sympathetic amines (epinephrine and norepinephrine)
and thromboxane A2, and a decrease in the levels of vasodilators, such as endo-
thelium-derived relaxing factor, atrial natriuretic factor, bradykinin, and prostaglan-
din E2,7 have been suggested to be among the contributing factors in the genesis of
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the vasospasm of the graft artery, but the real cause of this
vasospasm is poorly understood.
Various vasodilators have been used to prevent vaso-
spasm during CABG. Papaverine, a benzylisoquinoline al-
kaloid, is a widely used agent well known for its nonselec-
tive smooth muscle relaxant action. Although the efficacy of
papaverine for preventing graft spasm has been reported,8,9
some studies have found that papaverine caused cultured
saphenous vein endothelial cells to lose their viability,10
caused degeneration of smooth muscle cells of rat cerebral
arteries,11 or abolished the endothelium-dependent relax-
ation response to acetylcholine.12 These reports suggest that
papaverine might have detrimental effects on vascular tis-
sues, but the limitations of these studies are that the nature
of papaverine-induced endothelial injury has not been char-
acterized, and the cause of vascular damage caused by
papaverine solution remains unclear. One report has attrib-
uted the damage to the low pH of papaverine solution.13
In our laboratory we previously found that in cultured
endothelial and vascular smooth muscle cells, papaverine
induced apoptosis, but the low-pH solution did not.14 How-
ever, whether similar events occur in vivo during CABG is
not clear. Experiments with cultured cells might be limited
by the change in phenotype, reactivity, or both of these cells
during passage in an artificial culture environment. Such
changes might make these cells more vulnerable to papaverine.
The purpose of the present study is to investigate the effects of
papaverine on human ITAs from the standpoints of vascular
function and apoptosis. Canine ITAs were also used to sup-
plement the studies on human ITAs. We report here that
papaverine impairs ITA endothelial function and induces ap-
optosis of human ITA endothelial and smooth muscle cells.
Methods
Human ITA segments were obtained from patients undergoing
CABG. Consent from each patient was obtained before the oper-
ation, and we followed the institutional guidelines on the use of
human tissues. From each patient, a piece of the terminal segment,
which is generally discarded during operations, was collected in
oxygenated physiologic salt solution (PSS) with the following
composition: NaCl, 119 mmol/L; KCl, 4.7 mmol/L; MgSO4 7H2O,
1.17 mmol/L; KH2PO4, 1.18 mmol/L; N-2-hydroxyethylpipera-
zine-N-2-ethanesulfonic acid, 8 mmol/L; NaHCO3, 25 mmol/L;
glucose, 11.1 mmol/L; and CaCl2, 2.5 mmol/L, with antibiotic-
antimycotic at 4°C. Care was taken to ensure minimal handling of
the ITA during the operation and on subsequent transportation to
minimize damage. The terminal segments of the ITAs were dis-
sected with the connective tissues attached, and the ITAs were
handled by using the connective tissues. The ITAs were trans-
ported to our laboratory within 60 minutes on ice. Most of the
ITAs were used the same day. Three of these segments (2 treated
and 1 control segment) were stored in the oxygenated PSS at 4°C
and used the following morning. Maximum storage time was 16
hours. We did not notice any difference in response between ITAs
that were stored overnight versus those that were studied the same
day. This is consistent with our findings in rat mesenteric arteries,
in which we found that these arteries can be stored for up to 48
hours without affecting their functional responses to agonists.
The time between papaverine application and the collection of
the graft ranged from 15 to 45 minutes, depending on the com-
plexity of the operation. Papaverine was diluted in Plasmalyte and
used at a concentration of 1.7 mmol/L (pH 6.17) or diluted in
normal saline and used at a concentration of 17.0 mmol/L (pH 3.83).
Papaverine was applied in ambient temperature on the adventitial side
of ITAs with either a soaked gauze or by spreading the solution with
a 23-gauge needle. In some cases of CABG, a small piece of the distal
segment of the ITA was obtained before the surgeon applied the
Figure 1. Effects of papaverine treatment on the relaxation ef-
fects of acetylcholine (ACh) on human (A) and canine (B) ITAs and
the influence of acidified saline (pH 3.9) on acetylcholine-induced
relaxation in canine ITAs (C). *P < .05, **P < .01 versus respec-
tive control (human: n  4 for control and n  12 for treated; dog:
n  3 for control and n  5 for treated).
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vasodilator, and this served as our control vessel. The experimenters
were blinded to the type of papaverine treatment to the ITA, so that
any effects of papaverine on the ITA function and morphology were
correlated after the experiments were done.
Functional Studies
After removal of the connective tissues, the ITA segments were cut
into 4- to 5-mm-long rings. A wire myograph system was used to
study the contraction and relaxation of the ITA. Generally, 2 to 4
rings were obtained from each ITA segment, and each ring was
used to test one agent, so that in the analyses, n represents the
number of patients from which the samples were obtained. The
resting tension was set at 4 g. We have established in our prelim-
inary experiments that this is the optimal tension for the human
ITA. After equilibration for at least 60 minutes, the ITA was
challenged with 100 mmol/L KCl twice at an interval of 30
minutes. Endothelium-dependent relaxation to acetylcholine was
assessed in phenylephrine (106 mol/L to 3  106 mol/L)–
precontracted vessels (approximately 80% of the maximal contrac-
tion) and was expressed as a percentage of the maximal relaxation
by using sodium nitroprusside (3  103 mol/L). The contractile
properties of the ITA to phenylephrine and U46619 were ex-
pressed as a percentage of KCl (100 mmol/L)–induced contraction.
Canine ITAs were obtained from mixed-breed pound-source
dogs. The care of the animals was in accordance with the guide-
lines of the Canadian Council on Animal Care. ITAs were obtained
from the dogs after achievement of sodium pentobarbital anesthe-
sia. Papaverine solution or acidified saline or normal saline solu-
tion was injected into the lumen of the vessel, with all branches
and both ends of the vessel tied off with surgical sutures to prevent
leakage from the vessel. After 1 hour of incubation at room
temperature, the vessels were washed twice in PSS with the ties at
the 2 ends loosened and then cut into rings 4 to 5 mm in length for
functional studies.
Figure 2. Effects of papaverine treatment on phenylephrine-in-
duced contraction in human (A) and canine (B) ITAs (human: n 
4 for control and n  11 for treated; dog: n  4 for control and n
 4 for treated).
Figure 3. Effects of papaverine treatment on U46619-induced con-
traction of human ITA (A) and contraction of canine ITA to U46619
(B) (human: n  3 for control and n  14 for treated; dog: n  4).
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Detection of Apoptotic Cells in the ITA
Segments of the ITA were prepared in sterilized conditions and
then incubated with cell culture media (Dulbecco’s modified Ea-
gle’s medium; Gibco BRL, Life Technologies, Inc, Rockville, Md)
supplemented with 10% fetal bovine serum, 2.5 g/mL fungizone,
50 g/mL gentamicin, 2 mmol/L glutamine, and 0.5 mmol/L
N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid in a humid-
ified incubator (37°C, 5% carbon dioxide, and 95% air). Twenty-
four hours after incubation, the ITA segments were fixed with 4%
neutral buffered formaldehyde for 1 hour under a consistent pres-
sure of 160 mm Hg for human ITAs and 80 mm Hg for canine
ITAs at room temperature. The application of pressure facilitated
quantification of apoptotic cells by ameliorating folding of endo-
thelial cells. To detect the apoptotic vascular smooth muscle cells,
digestion with elastase (40 U/mL) and collagenase (300 U/mL) for
1 hour or more was carried out to facilitate the penetration of the
reagents into the vessel wall. Apoptotic cells were stained with the
ApopTag in situ apoptosis detection kit, with some modifica-
tions,15 and viewed with a confocal microscope (Carl Zeiss LSM).
Arteries treated with DNase I (15 KU/mL for 30 minutes) to
induce DNA fragmentation were used as positive controls.
Quantification and Statistical Analysis
A confocal microscope was used to quantify the number of apo-
ptotic cells. Optical cross-sections of the ITA at a thickness of 10
m were cut. The images were analyzed by using Sicon Image
software (National Institutes of Health).16 The total number of
apoptotic endothelial cells was calculated from an area of 2.5 
104 m2 for both human and canine ITAs. The number of apo-
ptotic smooth muscle cells in the vessel was counted in a volume
of 0.5  107 m3 for human ITAs and 7  107 m3 for canine
ITAs. The values are expressed as means  SEM. In the contrac-
tility study the concentration causing 50% of the maximal response
(EC50) was estimated by fitting each concentration-response curve.
Statistical analyses were performed with SigmaStat software
(SPSS, Inc). Two-way repeated-measures analysis of variance was
used to determine any significance between the treatment and
control groups. Post hoc unpaired t tests were used to identify the
concentrations at which statistically significant differences occurred.
Chemicals
Acetylcholine, DNase I, phenylephrine, papaverine hydrochloride,
sodium nitroprusside, and U46619 were purchased from Sigma
Chemical Co; ApopTag plus the fluorescein indirect immunoflu-
orescence kit was purchased from Intergen Co; and Dulbeccos’s
modified Eagle’s medium was purchased from Gibco BRL.
Results
Effects of Papaverine on Endothelium-Dependent
Relaxation
Endothelium-dependent relaxation was tested with acetyl-
choline in phenylephrine-precontracted vessel rings. As
shown in Figure 1, human ITAs treated with papaverine
Figure 4. Confocal images of human ITA stained with the terminal deoxynucleotidyl transferase–mediated dUTP
nick end-labeling assay: A and D, ITA treated with papaverine; B and E, control arteries; C and F, positive control
treated with DNase I. Apoptotic endothelial and smooth muscle cells appear as bright dots. LM, Lumen of the
vessel.
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(1.7-17.0 mmol/L) during grafting and canine ITAs incu-
bated with papaverine (10 mmol/L) showed significantly
less relaxation to acetylcholine: the maximal relaxation
(control vs treated) values were 68.35%  7.13% versus
47.5%  9.32% in human ITAs and 74.8%  5.5% versus
34.3%  8.5% in canine ITAs. There was no difference
between ITAs from human subjects and dogs in their re-
sponse to acetylcholine with or without papaverine treat-
ment. Acidified saline (pH 3.9) did not affect the relaxation
of canine ITA to acetylcholine significantly (maximal re-
laxation: 81.1%  7.3% for control and 74.8%  7.4% for
acidified saline–treated ITAs). We did not detect any sig-
nificant difference among the human ITAs as a result of the
different methods used to apply papaverine during CABG.
Effects of Papaverine on Smooth Muscle Contractility
Phenylephrine contracted human and canine ITA in a con-
centration-dependent manner with EC50s of 1.15  0.19
mol/L (n  4) and 0.85  0.13 mol/L (n  4), respec-
tively. Human and canine ITAs treated with papaverine
showed similar EC50s (5.1  0.19 mol/L [n  11] and
1.01 0.18 mol/L [n 4]) and percentage contractions to
phenylephrine as those of the control vessels (Figure 2).
U46619, a thromboxane A2/prostaglandin H2 receptor
agonist, dose-dependently contracted human ITAs in the
range of 3 1010 mol/L to 106 mol/L with an EC50 of
5.02  2.2 nmol/L (n  3). Papaverine treatment did not
significantly affect the EC50 (4.4 1.1 nmol/L, n 14) and
the percentage of contraction to U46619 in human ITAs
(Figure 3, A). Canine ITAs were less responsive to U46619
than human ITAs (Figure 3, B).
Assessment of Apoptotic Endothelial and Smooth
Muscle Cells
In control arteries only a few apoptotic cells were detected
in some samples. There was no difference between control
ITAs from human subjects and dogs in the number of apoptotic
cells in the endothelium and smooth muscle cells. Human or
canine ITAs treated with papaverine showed a significantly
higher incidence of apoptotic endothelial and smooth muscle
cells than their respective control segments (Figures 4-6).
Discussion
The main purpose of this study was to determine whether
the use of papaverine during CABG affects endothelial and
smooth muscle function, induces apoptosis in human ITA
Figure 5. Confocal images of canine ITA stained with the terminal deoxynucleotidyl transferase–mediated dUTP
nick end-labeling assay: A and D, ITA treated with papaverine; B and E, control arteries; C and F, positive control
treated with DNase I. Apoptotic endothelial and smooth muscle cells appear as bright dots. LM, Lumen of the
vessel.
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grafts, or both. We found that papaverine impairs endothe-
lium-dependent relaxation and induced prominent apoptosis
of endothelial and smooth muscle cells. The impaired en-
dothelium-dependent relaxation might be related to the in-
duction of apoptosis in endothelial cells.
The effects of papaverine on endothelium function have
been studied in human subjects, but the reports were incon-
sistent. Hillier and colleagues17 found that intraluminal pa-
paverine treatment during CABG did not impair endotheli-
um-dependent relaxation, whereas Schyvens and
associates12 found that papaverine treatment abolished en-
dothelium-dependent relaxation of the graft artery. In the
human radial artery He18 also found that papaverine abol-
ished acetylcholine-induced relaxation. In this study we
found that human ITAs treated with papaverine showed an
attenuated relaxation response to acetylcholine compared
with that of untreated control vessels. A similar result was
obtained with canine ITAs when 102 mol/L papaverine
was administered by means of intraluminal injection. There-
fore, in contrast with previous findings, our results showed
that papaverine attenuated but did not abolish endothelium-
dependent relaxation of human ITAs.
One previous study has suggested that the acidity of
papaverine solution might be the cause of damage to vas-
cular cells.13 Papaverine hydrochloride is dissolvable only
in acidic condition (pH 3.9, 102 mol/L), and it is known
that extracellular acidity lowers intracellular pH, as shown
in polymorphonuclear leukocytes.19 However, our results
with canine ITAs showed that treatment with acidified sa-
line solution, which is of the same pH as papaverine solu-
tion, did not affect acetylcholine-induced relaxation. There-
fore, it could be concluded that papaverine itself, and not the
low pH of its solution, induces endothelial cell damage.
The mechanism for this endothelial function impairment
by papaverine might be the genesis of apoptosis of the
endothelial cells. Consistent with what we have found in our
previous study with cultured cells,14 here we found that
papaverine induced a prominent genesis of apoptosis in the
endothelial cells of human and canine ITAs. It is well
known that endothelium contributes to the regulation of
vascular tone by releasing vasorelaxing agents, such as
nitric oxide, prostacyclin, or constrictor agents, such as
endothelin. Because cells that undergo apoptosis will cease
their normal function and will either detach from the vessel
or be engulfed by neighboring cells, the initiation of apo-
ptosis will affect the function of the endothelium. Papaver-
ine might induce apoptosis (1) by increasing the intracellu-
lar level of cyclic adenosine monophosphate by slowing
down or inhibiting the decomposition of cyclic adenosine
monophosphate,20-22 (2) by acting as a calcium antago-
nist,23,24 and (3) interrupting mitochondrial function.25
The effect of papaverine on vessel contractility was also
examined in this study. We elected to use phenylephrine and
U46619 as agonists to simulate sympathetic nerve activa-
tion and local release of thromboxane A2. In human ITAs
U46619 is a stronger agonist than phenylephrine both in
potency and sensitivity, whereas in canine ITAs contraction
to phenylephrine was stronger than that to U46619. This is
probably a result of species difference. Surprisingly, despite
the presence of apoptotic smooth muscle cells caused by
papaverine treatment in both human and canine ITAs, the
contractility of the ITA to these agonists was not affected. A
study by Chester and coworkers26 using intraluminal ad-
ministration of papaverine also found that papaverine did
not affect the contractility of the ITA. The influence of
papaverine on smooth muscle contractility is different from
that on the endothelium, where an association could be
made between an impairment of endothelium-dependent
Figure 6. Summary of papaverine-induced apoptosis in human (n
 4 for control, n  9 for treated) and canine (n  4 for control,
n  6 for treated) ITAs. *P < .05, **P < .01 versus respective
control.
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relaxation response and the presence of apoptotic cells
caused by papaverine treatment. This difference might be
related to the relative abundance of smooth muscle cells in
a vessel wall compared with the endothelial cells, which
consist of only one cell layer, so that the functional conse-
quence of the damage is more immediate and obvious with
endothelial cells than with smooth muscle cells. The con-
tractility of smooth muscles to some circulating contractile
agents, including norepinephrine, might increase as a result
of the loss of endothelial cells.27,28 Furthermore, phagocy-
tosis of apoptotic endothelial cells by their neighbors29
could expose smooth muscle cells directly to vasoactive
agents in the blood stream because of the loss of the endo-
thelial protective barrier.30 Therefore, the overall contractile
response will be affected by both endothelial dysfunction
and smooth muscle cell apoptosis, depending on which is
the prevailing factor. The long-term consequence of the
damage to smooth muscle cells in relation to vessel wall
function is unknown and remains to be studied. However,
because the maintenance of the integrity of vascular cells is
important for their functions, it is essential that we seek out
other vasodilators that are less damaging to the ITA for
cardiac surgery. The use of verapamil plus nitroglycerin
solution is one of the possible alternatives.18
In summary, we found that papaverine impairs endothe-
lial function and induces apoptosis of endothelial and
smooth muscle cells of human and canine ITAs. Because
the integrity of graft tissue is important for its function, we
suggest that it will be prudent to use other vasodilators that
are less damaging to the ITA for cardiac surgery.
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